Cargando…
Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
Pulmonary delivery has high bioavailability, a large surface area for absorption, and limited drug degradation. Particle engineering is important to develop inhalable formulations to improve the therapeutic effect. In our work, the poorly water-soluble meloxicam (MX) was used as an active ingredient...
Autores principales: | Party, Petra, Bartos, Csilla, Farkas, Árpád, Szabó-Révész, Piroska, Ambrus, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913764/ https://www.ncbi.nlm.nih.gov/pubmed/33546452 http://dx.doi.org/10.3390/pharmaceutics13020211 |
Ejemplares similares
-
Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
por: Benke, Edit, et al.
Publicado: (2020) -
Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam
por: Ambrus, Rita, et al.
Publicado: (2022) -
The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
por: Benke, Edit, et al.
Publicado: (2021) -
Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel “Nano-in-Micro” Structured Dry Powder Inhaler System
por: Party, Petra, et al.
Publicado: (2023) -
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
por: Karimi, Keyhaneh, et al.
Publicado: (2016)